| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Cuong V. Do | President & CEO, Director | $288K | Mar 4, 2024 | ||
| Richard J. Berman | Director | $117K | Nov 9, 2023 | ||
| James Paul Lang | Director | $116K | Nov 9, 2023 | ||
| Jonathan Adams | EVP Liver Cirrhosis Programs | $82.2K | Feb 2, 2022 | ||
| Penelope Markham | EVP Liver Cirrhosis R&D | $80.9K | Feb 16, 2023 | ||
| Steve Gorlin | Director | $78.3K | Nov 9, 2023 | ||
| Robert J. Hariri | Director | $71.4K | Nov 9, 2023 | ||
| Sigmund Rogich | Director | $71.4K | Nov 9, 2023 | ||
| Clarence Ahlem | EVP Neuroscience Product Dev. | $62.8K | Feb 16, 2023 | ||
| Christopher Reading | EVP Neuroscience R&D | $62.8K | Feb 16, 2023 | ||
| Joseph M. Palumbo | Chief Medical Officer | $56.5K | Jun 7, 2023 | ||
| Joanne Wendy Kim | Chief Financial Officer | $44.5K | Dec 11, 2023 | ||
| Sherman Michael Edward | Director | Nov 9, 2023 | |||
| Terren S. Peizer | Director, 10%+ Owner | Nov 23, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|